Evaluating Preoperative Intravenous Iron and Erythropoietin Treatment and Outcomes in Cardiac Surgery Patients.

Alireza Jahangiri Fard Azita Chegini Amir Hossein Maghari

Published in: Anesthesiology and pain medicine (2023)

Infection (P = 0.258), mortality rate (P = 0.440), and RBC utilization (P = 0.469) in the two groups of injection and non-injection were not significantly different.

Keyphrases

cardiac surgery
end stage renal disease
chronic kidney disease
newly diagnosed
prognostic factors
high dose
risk factors
type diabetes
low dose
combination therapy
insulin resistance
patient reported
replacement therapy
iron deficiency